Stock 6893 HIN SANG GROUP (INTERNATIONAL) HOLDING CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hin Sang Group (International) Holding Co. Ltd.

Equities

6893

KYG4590V1023

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:06 2024-04-30 am EDT 		5-day change 1st Jan Change
0.3 HKD -3.23% Intraday chart for Hin Sang Group (International) Holding Co. Ltd. -6.25% -10.45%
Feb. 19 Hin Sang Group (International) Holding Co. Ltd. Announces Change of Company Secretary, Effective 19 February 2024 CI
2023 Hin Sang Group Narrows Fiscal H1 Loss MT

Business Summary

Hin Sang Group (International) Holding Co. Ltd. is an investment holding company principally engaged in development, marketing and sales of care products, healthcare products and household products under various brands. The Company operates its business through three segments. The Product Development segment is engaged in the sales of products developed by the Company under own brands. The Brand Development and Management segment is engaged in the sales and distribution of products with exclusive distribution rights. The Trading of Goods segment is engaged in the sales and distribution of products purchased from authorized dealers, independent traders, manufacturers and parallel importers.

Number of employees: 265

Sales per Business

HKD in Million2022Weight2023Weight Delta
Product Development
96.5 %
117 97.3 % 79 96.5 % -32.94%
Brand Development and Management
1.7 %
1 1.1 % 1 1.7 % +1.70%
Trading of Goods
0.9 %
0 0.3 % 1 0.9 % +140.97%
Healthcare
0.9 %
2 1.3 % 1 0.9 % -56.78%

Sales per region

HKD in Million2022Weight2023Weight Delta
Hong Kong
56.5 %
72 60.1 % 46 56.5 % -36.46%
China
43.5 %
48 39.9 % 35 43.5 % -26.34%

Managers

Managers TitleAgeSince
Siu Hin Pang CEO
 Chief Executive Officer 59 10-09-30
Wing Keung Mak CTO
 Chief Tech/Sci/R&D Officer 57 04-04-30
Lai Man Kwan BRD
 Director/Board Member 52 -
Wah Kit Cheuk SAM
 Sales & Marketing 41 -
Po King Cheung SEC
 Corporate Secretary 44 Feb. 18

Members of the board

Members of the board TitleAgeSince
Luk Shiu Lee BRD
 Director/Board Member 66 14-09-24
Chi Kit Lau BRD
 Director/Board Member 79 17-10-15
Wai Ling Wong BRD
 Director/Board Member 63 10-10-31
Siu Hin Pang CEO
 Chief Executive Officer 59 10-09-30
Lai Man Kwan BRD
 Director/Board Member 52 -
Sing Hing Tang BRD
 Director/Board Member 55 10-10-31
Shan Shan Tian BRD
 Director/Board Member 40 21-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,091,796,000 273,946,000 ( 25.09 %) 0 25.09 %

Shareholders

NameEquities%Valuation
Siu Hin Pang
51.53 %
562,627,000 51.53 % 23 M $
FULLSHARE HOLDINGS LIMITED
22.90 %
250,000,000 22.90 % 10 M $
Lai Man Kwan
0.4784 %
5,223,000 0.4784 % 213 568 $

Company contact information

Hin Sang Group (International) Holding Co. Ltd.

Unit 1213-1215, 12/F Seapower Tower, Concordia Plaza

, Hong Kong

+

http://www.hinsanggroup.com
address Hin Sang Group (International) Holding Co. Ltd.(6893)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
HIN SANG GROUP (INTERNATIONAL) HOLDING CO. LTD. Stock Hin Sang Group (International) Holding Co. Ltd.
-10.45% 41.88M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+34.00% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.25% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.75% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.53% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.95% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.70% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-4.89% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6893 Stock
  4. Company Hin Sang Group (International) Holding Co. Ltd.